Oftentimes medical practice recommendations are undergirded by expert opinion rather than by multiple randomized control trials and can't quite answer the questions patients and their families have about what treatment is best for them, write Francis Collins, the director of the US National Institutes of Health, Kathy Hudson, the deputy director for science, outreach, and policy at NIH, and their colleagues in a commentary appearing in the Journal of the American Medical Informatics Asso

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.